rs531550505
- chr15-22786677-AGCGGCGGCGGCGGCGGCGGCG-A
- chr15-22786677-AGCGGCGGCGGCGGCGGCGGCG-AGCG
- chr15-22786677-AGCGGCGGCGGCGGCGGCGGCG-AGCGGCG
- chr15-22786677-AGCGGCGGCGGCGGCGGCGGCG-AGCGGCGGCG
- chr15-22786677-AGCGGCGGCGGCGGCGGCGGCG-AGCGGCGGCGGCG
- chr15-22786677-AGCGGCGGCGGCGGCGGCGGCG-AGCGGCGGCGGCGGCG
- chr15-22786677-AGCGGCGGCGGCGGCGGCGGCG-AGCGGCGGCGGCGGCGGCG
- chr15-22786677-AGCGGCGGCGGCGGCGGCGGCG-AGCGGCGGCGGCGGCGGCGGCGGCG
- chr15-22786677-AGCGGCGGCGGCGGCGGCGGCG-AGCGGCGGCGGCGGCGGCGGCGGCGGCG
- chr15-22786677-AGCGGCGGCGGCGGCGGCGGCG-AGCGGCGGCGGCGGCGGCGGCGGCGGCGGCG
- chr15-22786677-AGCGGCGGCGGCGGCGGCGGCG-AGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCG
- chr15-22786677-AGCGGCGGCGGCGGCGGCGGCG-AGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCG
- chr15-22786677-AGCGGCGGCGGCGGCGGCGGCG-AGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCG
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP3BS2
The NM_144599.5(NIPA1):c.27_47delGGCGGCGGCGGCGGCGGCGGC(p.Ala10_Ala16del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000448 in 1,071,500 control chromosomes in the GnomAD database, including 3 homozygotes. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144599.5 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegia 6Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NIPA1 | NM_144599.5 | c.27_47delGGCGGCGGCGGCGGCGGCGGC | p.Ala10_Ala16del | disruptive_inframe_deletion | Exon 1 of 5 | ENST00000337435.9 | NP_653200.2 | |
| NIPA1 | NM_001142275.1 | c.-48+435_-48+455delGGCGGCGGCGGCGGCGGCGGC | intron_variant | Intron 1 of 4 | NP_001135747.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000344 AC: 5AN: 145406Hom.: 0 Cov.: 6 show subpopulations
GnomAD2 exomes AF: 0.000347 AC: 7AN: 20176 AF XY: 0.000474 show subpopulations
GnomAD4 exome AF: 0.0000464 AC: 43AN: 926094Hom.: 3 AF XY: 0.0000723 AC XY: 32AN XY: 442826 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000344 AC: 5AN: 145406Hom.: 0 Cov.: 6 AF XY: 0.0000424 AC XY: 3AN XY: 70686 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 6 Uncertain:1
This variant, c.27_47del, results in the deletion of 7 amino acid(s) of the NIPA1 protein (p.Ala10_Ala16del), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with NIPA1-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at